Overview
David Grimwade practices in London, United Kingdom. Mr. Grimwade is rated as an Advanced expert by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. His top areas of expertise are Acute Promyelocytic Leukemia, Acute Myeloid Leukemia (AML), Leukemia, and Acute Myeloblastic Leukemia without Maturation.
His clinical research consists of co-authoring 79 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Acute Myeloblastic Leukemia with Maturation.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Promyelocytic LeukemiaMr. Grimwade isElite. Learn about Acute Promyelocytic Leukemia.
- Distinguished
- Acute Myeloid Leukemia (AML)Mr. Grimwade isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMr. Grimwade isDistinguished. Learn about Leukemia.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Experienced
- LeukocytosisMr. Grimwade isExperienced. Learn about Leukocytosis.
- MyelofibrosisMr. Grimwade isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Mr. Grimwade isExperienced. Learn about Myeloproliferative Neoplasms (MPN).